Perceptual Outcome Measures for Supplementing Transcription Intelligibility in Speakers with Parkinson's Disease and Mild Dysarthria.
Folia Phoniatr Logop.
2026 Feb 3;:1-14. doi: 10.1159/000550174. [Epub ahead of print] PubMed PMID:
41632721; PubMed Central PMCID:
PMC12871864.
Ventral tegmental area dopamine controls timing variability. 2025 October. DOI: 10.1101/2025.10.27.684913.
Linear predictive coding electroencephalography algorithms predict Parkinson’s disease mortality using out-of-sample tests. 2025 July. DOI: 10.1101/2025.07.07.25331047.
Amphetamine increases timing variability by degrading prefrontal temporal encoding.
Neuropharmacology. 2025 September. doi: 10.1016/j.neuropharm.2025.110486.
Theta-frequency subthalamic nucleus stimulation increases decision threshold.
Brain Stimulation. 2025 July. doi: 10.1016/j.brs.2025.05.105.
Cortical connectivity predicts cognition across time in Parkinson’s disease. 2025 May. DOI: 10.1101/2025.05.13.25327462.
Complementary cognitive roles for D2-MSNs and D1-MSNs during interval timing.
eLife. 2025 January. doi: 10.7554/eLife.96287.
Complementary cognitive roles for D2-MSNs and D1-MSNs during interval timing.
eLife. 2025 January. doi: 10.7554/eLife.96287.4.
Computational Properties of the Prefrontal Cortex.
The Journal of Neuroscience. 2025 September. doi: 10.1523/JNEUROSCI.1093-25.2025.
Theta-frequency subthalamic nucleus stimulation increases decision threshold.
Brain Stimul.
2025 Jul-Aug;18(4):1021-1027. doi: 10.1016/j.brs.2025.05.105. Epub 2025 May 13. PubMed PMID:
40374107; PubMed Central PMCID:
PMC12392301.
Amphetamine increases timing variability by degrading prefrontal temporal encoding.
Neuropharmacology.
2025 Sep 1;275:110486. doi: 10.1016/j.neuropharm.2025.110486. Epub 2025 May 3. PubMed PMID:
40324651; PubMed Central PMCID:
PMC12261982.
Alpha-Synuclein Pre-Formed Fibrils Injected into Prefrontal Cortex Primarily Spread to Cortical and Subcortical Structures.
J Parkinsons Dis.
2024;14(1):81-94. doi: 10.3233/JPD-230129. PubMed PMID:
38189765; PubMed Central PMCID:
PMC10836574.
Amphetamine increases timing variability by degrading prefrontal ramping activity. 2024 September. DOI: 10.1101/2024.09.26.615252.
Cortical and subcortical functional connectivity and cognitive impairment in Parkinson’s disease.
NeuroImage: Clinical. 2024. doi: 10.1016/j.nicl.2024.103610.
Resting-state EEG measures cognitive impairment in Parkinson’s disease.
npj Parkinson's Disease. 2024 January. doi: 10.1038/s41531-023-00602-0.
Mice Expressing A53T/A30P Mutant Alpha-Synuclein in Dopamine Neurons Do Not Display Behavioral Deficits.
eneuro. 2024 February. doi: 10.1523/ENEURO.0170-23.2023.
LRRK2 G2019S Promotes Colon Cancer Potentially via LRRK2–GSDMD Axis-Mediated Gut Inflammation.
Cells. 2024 March. doi: 10.3390/cells13070565.
Complementary cognitive roles for D2-MSNs and D1-MSNs in interval timing. 2024 March. DOI: 10.7554/eLife.96287.1.
LRRK2 G2019S Promotes Colon Cancer Potentially via LRRK2–GSDMD Axis-Mediated Gut Inflammation.
Cells. 2024 March. doi: 10.3390/cells13070565.
Association of Terazosin, Doxazosin, or Alfuzosin Use and Risk of Dementia With Lewy Bodies in Men.
Neurology. 2024 July. doi: 10.1212/WNL.0000000000209570.
Complementary opposing D2-MSNs and D1-MSNs dynamics during interval timing. 2024 August. DOI: 10.7554/eLife.96287.2.
Cognition falters at ~4 Hz in Parkinson’s disease.
Trends in Cognitive Sciences. 2024 September. doi: 10.1016/j.tics.2024.06.002.
Renovating the Barnes maze for mouse models of Dementia with STARR FIELD: A 4-day protocol that probes learning rate, retention and cognitive flexibility. 2024 December. DOI: 10.1101/2024.11.30.625516.
Prefrontal projections to the bed nuclei of the stria terminalis modulate the specificity of aversive memories. 2024 October. DOI: 10.21203/rs.3.rs-4241372/v1.
Complementary cognitive roles for D2-MSNs and D1-MSNs during interval timing. 2024 November. DOI: 10.7554/eLife.96287.3.
Generation and validation of a D1 dopamine receptor Flpo knock-in mouse.
J Neurosci Methods.
2025 Mar;415:110345. doi: 10.1016/j.jneumeth.2024.110345. Epub 2024 Dec 17. PubMed PMID:
39701542; PubMed Central PMCID:
PMC11878109.
Complementary cognitive roles for D2-MSNs and D1-MSNs during interval timing.
bioRxiv.
2024 Sep 6;. doi: 10.1101/2023.07.25.550569. PubMed PMID:
37546735; PubMed Central PMCID:
PMC10402049.
Cognition falters at ~4 Hz in Parkinson's disease.
Trends Cogn Sci.
2024 Sep;28(9):789-791. doi: 10.1016/j.tics.2024.06.002. Epub 2024 Jul 12. PubMed PMID:
39003229; PubMed Central PMCID:
PMC11458154.
Sustained behaviour: Encoding of cumulative experience in the anterior cingulate.
Curr Biol.
2024 Jul 8;34(13):R616-R618. doi: 10.1016/j.cub.2024.05.070. PubMed PMID:
38981423.
Association of Terazosin, Doxazosin, or Alfuzosin Use and Risk of Dementia With Lewy Bodies in Men.
Neurology.
2024 Jul 23;103(2):e209570. doi: 10.1212/WNL.0000000000209570. Epub 2024 Jun 19. PubMed PMID:
38896813; PubMed Central PMCID:
PMC11226317.
Regulator of G protein signaling 6 (RGS6) in dopamine neurons promotes EtOH seeking, behavioral reward, and susceptibility to relapse.
Psychopharmacology (Berl).
2024 Nov;241(11):2255-2269. doi: 10.1007/s00213-024-06631-8. Epub 2024 Jun 10. PubMed PMID:
38856764; PubMed Central PMCID:
PMC11518640.
Cortical and subcortical functional connectivity and cognitive impairment in Parkinson's disease.
Neuroimage Clin.
2024;42:103610. doi: 10.1016/j.nicl.2024.103610. Epub 2024 Apr 25. PubMed PMID:
38677099; PubMed Central PMCID:
PMC11066685.
Sex similarities and dopaminergic differences in interval timing.
Behav Neurosci.
2024 Apr;138(2):85-93. doi: 10.1037/bne0000577. PubMed PMID:
38661668; PubMed Central PMCID:
PMC11512544.
LRRK2 G2019S Promotes Colon Cancer Potentially via LRRK2-GSDMD Axis-Mediated Gut Inflammation.
Cells.
2024 Mar 23;13(7). doi: 10.3390/cells13070565. PubMed PMID:
38607004; PubMed Central PMCID:
PMC11011703.
Rurality modifies the association between symptoms and the diagnosis of amyotrophic lateral sclerosis.
Amyotroph Lateral Scler Frontotemporal Degener.
2024 Aug;25(5-6):517-527. doi: 10.1080/21678421.2024.2315185. Epub 2024 Feb 14. PubMed PMID:
38353166; PubMed Central PMCID:
PMC11840969.
Mice Expressing A53T/A30P Mutant Alpha-Synuclein in Dopamine Neurons Do Not Display Behavioral Deficits.
eNeuro.
2024 Feb;11(2). doi: 10.1523/ENEURO.0170-23.2023. Print 2024 Feb. PubMed PMID:
38351057; PubMed Central PMCID:
PMC10866330.
Resting-state EEG measures cognitive impairment in Parkinson's disease.
NPJ Parkinsons Dis.
2024 Jan 3;10(1):6. doi: 10.1038/s41531-023-00602-0. PubMed PMID:
38172519; PubMed Central PMCID:
PMC10764756.
Lower risk of dementia with Lewy bodies among users of glycolysis enhancing drugs in a new user, active comparator design. 2023 December. DOI: 10.1101/2023.12.05.23299455.
Evoked mid-frontal activity predicts cognitive dysfunction in Parkinson’s disease.
Journal of Neurology, Neurosurgery & Psychiatry. 2023 November. doi: 10.1136/jnnp-2022-330154.
Regulator of G protein signaling 6 (RGS6) in ventral tegmental area (VTA) dopamine neurons promotes EtOH seeking, behavioral reward and susceptibility to relapse. 2023 October. DOI: 10.1101/2023.10.24.563844.
Neurohistopathological Findings of the Brain Parenchyma After Long-Term Deep Brain Stimulation: Case Series and Systematic Literature Review. 2023 November. DOI: 10.1101/2023.11.23.23298888.
Glycolysis-enhancing α1-adrenergic antagonists modify cognitive symptoms related to Parkinson’s disease.
npj Parkinson's Disease. 2023 March. doi: 10.1038/s41531-023-00477-1.
Resting-state EEG measures cognitive impairment in Parkinson’s disease. 2023 March. DOI: 10.21203/rs.3.rs-2666578/v1.
Does Black vs. White race affect practitioners’ appraisal of Parkinson’s disease?.
npj Parkinson's Disease. 2023 July. doi: 10.1038/s41531-023-00549-2.
Sex similarities and dopaminergic differences in interval timing. 2023 May. DOI: 10.1101/2023.05.05.539584.
Alpha-synuclein pre-formed fibrils injected into prefrontal cortex primarily spread to cortical and subcortical structures and lead to isolated behavioral symptoms. 2023 February. DOI: 10.1101/2023.01.31.526365.
Mice expressing A53T / A30P mutant alpha-synuclein in dopamine neurons do not display behavioral deficits. 2023 May. DOI: 10.1101/2023.05.25.542172.
Salience network and cognitive impairment in Parkinson’s disease. 2023 October. DOI: 10.1101/2023.10.13.23296825.
Rurality Modifies the Association Between Symptoms and the Diagnosis of Amyotrophic Lateral Sclerosis. 2023 October. DOI: 10.1101/2023.10.13.23297024.
Complementary cognitive roles for D2-MSNs and D1-MSNs during interval timing. 2023 July. DOI: 10.1101/2023.07.25.550569.
What would you like to do?